Filter by category
  • All
  • Blog
  • Congress
  • Scientific resource
  • Webinar
  • Poster
  • Scientific publication
  • Press release
  • Press coverage
  • News
Filter by category
Circle Oncodesign Services
Scientific publications | Oncodesign Services
Scientific publication
17/05/2018

Radiolabeled F(ab’)2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models

Radiolabeled F(ab')2-cetuximab for theranostic purposes in colorectal and skin tumor-bearing mice models

Read more
Financial Press Release | Oncodesign
Press release
23/04/2018

Oncodesign announces the nomination of Arnaud Lafforgue as Chief Financial Officer

Read more
Scientific paper - Ressources
Poster
14/04/2018

19th Drug Discovery Summit – Development of a high throughput in vitro screening platform to identify novel inducers of immunological cell death

Read more
Financial Press Release | Oncodesign
Press release
27/03/2018

Oncodesign concludes a long term service-based partnership with ERYTECH in oncology

Read more
Ressources presse
19/03/2018

[FR] Parresia – L’intelligence artificielle au service de la médecine de précision

Read more
Ressources presse
22/02/2018

[FR] Biotech – Oncodesign, une plateforme unique de composés et de biomarqueurs

Read more
Ressources presse
31/01/2018

[FR] Boursorama – Interview de Philippe Genne, PDG d’Oncodesign

Read more
Ressources presse
23/01/2018

[FR] Mind Health – Oncodesign à l’affût d’acquisitions en bioinformatique

Read more
Scientific paper - Ressources
Poster
01/01/2018

EFMC-ISMC 2018 XXV – EFMC International Symposium on Medicinal Chemistry

Read more
Scientific paper - Ressources
Poster
01/01/2018

Bio IT Congress – OncoSNIPE, Al initiative designed to identify and characterize patients resistant or non responder to cancer treatments

Read more
Financial Press Release | Oncodesign
Press release
18/12/2017

Promising clinical results for innovative mutated anti-EGFR radiotracer in patients with non-small cell lung cancer

Read more
Financial Press Release | Oncodesign
17/12/2017

US – Oncodesign has entered into a services agreement with Eisai to develop a new personalized medicine program in earlier line metastatic breast cancer treatment

Read more